Leustatin and leukopenia Patient Reports February 13, 2012

Leustatin Side Effects Report #5020460-5
Leustatin side effect was reported by a Physician from JAPAN on May 06, 2005. Female patient, 61 years of age, was diagnosed with hairy cell leukaemia and was treated with Leustatin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, disseminated intravascular coagulation, leukopenia, mediastinal haematoma, pneumonitis, thrombocytopenia. Leustatin dosage: unknown. Patient died on 10/01/1999.

Leustatin Side Effects Report #4664450-0
Leustatin side effect was reported by a Physician from on May 06, 2005. Female patient, 61 years of age, was treated with Leustatin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, disseminated intravascular coagulation, leukopenia, mediastinal haematoma, pneumonitis, thrombocytopenia. Leustatin dosage: unknown. Patient died on 10/01/1999.

Leustatin Side Effects Report #6060535-5
Leustatin side effect was reported by a Physician from JAPAN on Jan 27, 2009. Male patient, weighting 99.21 lb, was diagnosed with mantle cell lymphoma and was treated with Leustatin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, enteritis infectious, gastric cancer, hypoalbuminaemia, hypoproteinaemia, leukopenia, lymphopenia. Leustatin dosage: unknown. During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE, RITUXIMAB. Patient died on 08/26/2008.

Leustatin Side Effects Report #6097765-2
Leustatin side effect was reported by a Physician from JAPAN on Jan 27, 2009. Male patient, weighting 99.21 lb, was diagnosed with mantle cell lymphoma and was treated with Leustatin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, enteritis infectious, gastric cancer, hypoalbuminaemia, hypoproteinaemia, leukopenia, lymphopenia. Leustatin dosage: unknown. During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE HYDROCHLORIDE, RITUXIMAB. Patient died on 08/26/2008.